Drug firm Orchid Chemicals & Pharmaceuticals today said it has received final US regulatory

RELATED ARTICLES Lupin gets USFDA approval for diabetes drug Fondaparinux injection issue resolved with USFDA: Dr Reddy's

approval for its drug Sumatriptan Succinate tablets used for the treatment of migraine attacks.

The company has received final US Food and Drug Administration (USFDA) approval, Orchid Chemicals said in a filing to the Bombay Stock Exchange (BSE).

The approval of Sumatriptan Succinate tablets are in the strengths of 25 mg, 50 mg and 100 mg.